Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) View the PDF document
Table of Contents
View the documentAbbreviations and acronyms used in this report
Open this folder and view contentsOpening ceremony
Open this folder and view contentsHerbal medicines
Open this folder and view contentsKeynote address
Open this folder and view contentsSafety of blood-derived products
Open this folder and view contentsAntimicrobial resistance - new initiatives
Open this folder and view contentsHarmonization I
Open this folder and view contentsHarmonization II
Open this folder and view contentsProtection of trial subjects in clinical trials
Open this folder and view contentsRegulating biotechnology products
Open this folder and view contentsRegulatory challenges: health sector reform and drug regulatory capacity
Open this folder and view contentsAccess to drugs and vaccines I
Open this folder and view contentsAccess to drugs and vaccines II
Open this folder and view contentsCounterfeit pharmaceutical products
Close this folderHomoeopathy
View the documentRegistration criteria for homoeopathic medicinal products in the United Arab Emirates
View the documentThe regulatory framework for homoeopathic medicinal products in Germany and in the European Union
View the documentRegulation of homoeopathic products in the United Kingdom
View the documentRecommendations
Open this folder and view contentsSafety monitoring
Open this folder and view contentsE-Commerce
Open this folder and view contentsCurrent topics
Open this folder and view contentsRegulatory challenges of new technologies
View the documentList of participants
View the documentBack cover
 

Registration criteria for homoeopathic medicinal products in the United Arab Emirates

Dr Sassan Behjat, United Arab Emirates

An increasing demand for homoeopathic treatment by the people of the United Arab Emirates (UAE) and a strong political will for regulation of complementary medicines have led to the establishment of a registration system for homoeopathic medicinal products under the Office of Complementary and Alternative Medicines of the Ministry of Health.

The objectives are to make available homoeopathic medicines within a legal framework that ensures consumer protection by guaranteeing that homoeopathic medicines imported into the UAE are of high quality, and that, for homoeopathic medicines sold directly to the public, adequate information is provided to allow informed decisions and to ensure safety of consumers.

Assessment is based on the safety and quality of the homoeopathic products. Manufacturers must be licensed and conform to GMP. Manufacturing processes should be in accordance with one of the internationally recognized pharmacopoeias. Restrictions are placed on advertisements, labelling and the dosage forms of the products. At the same time, homoeopathic practitioners are regulated and homoeopathic products can only be prescribed by licensed practitioners.

Continuing education of practitioners and pharmacists, and awareness programmes for the public, are of key importance.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014